Works matching IS 00099104 AND DT 2018 AND VI 191 AND IP 1

Results: 14

CD4+ T helper cells and regulatory T cells in active lupus nephritis: an imbalance towards a predominant Th1 response?
Published in:
Clinical & Experimental Immunology, 2018, v. 191, n. 1, p. 50, doi. 10.1111/cei.13050
By:
- Mesquita, Jr., D.;
- Kirsztajn, G. Mastroianni;
- Franco, M. F.;
- Reis, L. A.;
- Perazzio, S. F.;
- Mesquita, F. V.;
- Ferreira, V. da Silva;
- Andrade, L. E. Coelho;
- de Souza, A. W. Silva
Publication type:
Article
Complement regulatory proteins in kidneys of patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis.
Published in:
Clinical & Experimental Immunology, 2018, v. 191, n. 1, p. 116, doi. 10.1111/cei.13051
By:
- Cheng, L.;
- Gou, S.‐J.;
- Qiu, H.‐Y.;
- Ma, L.;
- Fu, P.
Publication type:
Article
Detection of ABCB5 tumour antigen-specific CD8+ T cells in melanoma patients and implications for immunotherapy.
Published in:
Clinical & Experimental Immunology, 2018, v. 191, n. 1, p. 74, doi. 10.1111/cei.13053
By:
- Borchers, S.;
- Maβlo, C.;
- Müller, C. A.;
- Tahedl, A.;
- Volkind, J.;
- Nowak, Y.;
- Umansky, V.;
- Esterlechner, J.;
- Frank, M. H.;
- Ganss, C.;
- Kluth, M. A.;
- Utikal, J.
Publication type:
Article
Lys63-polyubiquitination by the E3 ligase casitas B-lineage lymphoma-b (Cbl-b) modulates peripheral regulatory T cell tolerance in patients with systemic lupus erythematosus.
Published in:
Clinical & Experimental Immunology, 2018, v. 191, n. 1, p. 42, doi. 10.1111/cei.13054
By:
- Romo‐Tena, J.;
- Rajme‐López, S.;
- Aparicio‐Vera, L.;
- Alcocer‐Varela, J.;
- Gómez‐Martín, D.
Publication type:
Article
An increased CD25-positive intestinal regulatory T lymphocyte population is dependent upon Cox-2 activity in the Apcmin/+ model.
Published in:
Clinical & Experimental Immunology, 2018, v. 191, n. 1, p. 32, doi. 10.1111/cei.13055
By:
- Faluyi, O. O.;
- Fitch, P.;
- Howie, S. E. M.
Publication type:
Article
Immunoproteasome in the blood plasma of children with acute appendicitis, and its correlation with proteasome and UCHL1 measured by SPR imaging biosensors.
Published in:
Clinical & Experimental Immunology, 2018, v. 191, n. 1, p. 125, doi. 10.1111/cei.13056
By:
- Matuszczak, E.;
- Sankiewicz, A.;
- Debek, W.;
- Gorodkiewicz, E.;
- Milewski, R.;
- Hermanowicz, A.
Publication type:
Article
Issue Information.
Published in:
Clinical & Experimental Immunology, 2018, v. 191, n. 1, p. n/a, doi. 10.1111/cei.13027
Publication type:
Article
Self-dsDNA in the pathogenesis of systemic lupus erythematosus.
Published in:
Clinical & Experimental Immunology, 2018, v. 191, n. 1, p. 1, doi. 10.1111/cei.13041
By:
- Bai, Y.;
- Tong, Y.;
- Liu, Y.;
- Hu, H.
Publication type:
Article
Ovarian cancer stem cells promote tumour immune privilege and invasion via CCL5 and regulatory T cells.
Published in:
Clinical & Experimental Immunology, 2018, v. 191, n. 1, p. 60, doi. 10.1111/cei.13044
By:
- You, Y.;
- Li, Y.;
- Li, M.;
- Lei, M.;
- Wu, M.;
- Qu, Y.;
- Yuan, Y.;
- Chen, T.;
- Jiang, H.
Publication type:
Article
Chronic exposure of interleukin-13 suppress the induction of matrix metalloproteinase-1 by tumour necrosis factor α in normal and scleroderma dermal fibroblasts through protein kinase B/Akt.
Published in:
Clinical & Experimental Immunology, 2018, v. 191, n. 1, p. 84, doi. 10.1111/cei.13045
By:
- Brown Lobbins, M. L.;
- Shivakumar, B. R.;
- Postlethwaite, A. E.;
- Hasty, K. A.
Publication type:
Article
Selective HDAC6 inhibition decreases early stage of lupus nephritis by down-regulating both innate and adaptive immune responses.
Published in:
Clinical & Experimental Immunology, 2018, v. 191, n. 1, p. 19, doi. 10.1111/cei.13046
By:
- Ren, J.;
- Liao, X.;
- Vieson, M. D.;
- Chen, M.;
- Scott, R.;
- Kazmierczak, J.;
- Luo, X. M.;
- Reilly, C. M.
Publication type:
Article
Expression of human cathelicidin peptide LL-37 in inflammatory bowel disease.
Published in:
Clinical & Experimental Immunology, 2018, v. 191, n. 1, p. 96, doi. 10.1111/cei.13047
By:
- Kusaka, S.;
- Nishida, A.;
- Takahashi, K.;
- Bamba, S.;
- Yasui, H.;
- Kawahara, M.;
- Inatomi, O.;
- Sugimoto, M.;
- Andoh, A.
Publication type:
Article
DC-SIGN reacts with TLR-4 and regulates inflammatory cytokine expression via NF-κB activation in renal tubular epithelial cells during acute renal injury.
Published in:
Clinical & Experimental Immunology, 2018, v. 191, n. 1, p. 107, doi. 10.1111/cei.13048
By:
- Feng, D.;
- Wang, Y.;
- Liu, Y.;
- Wu, L.;
- Li, X.;
- Chen, Y.;
- Xu, C.;
- Yang, K.;
- Zhou, T.
Publication type:
Article
Is Behçet's disease a 'class 1-opathy'? The role of HLA-B*51 in the pathogenesis of Behçet's disease.
Published in:
Clinical & Experimental Immunology, 2018, v. 191, n. 1, p. 11, doi. 10.1111/cei.13049
By:
- Giza, M.;
- Koftori, D.;
- Chen, L.;
- Bowness, P.
Publication type:
Article

Works matching IS 00099104 AND DT 2018 AND VI 191 AND IP 1

CD4<sup>+</sup> T helper cells and regulatory T cells in active lupus nephritis: an imbalance towards a predominant Th1 response?

Complement regulatory proteins in kidneys of patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis.

Detection of ABCB5 tumour antigen-specific CD8<sup>+</sup> T cells in melanoma patients and implications for immunotherapy.

Lys63-polyubiquitination by the E3 ligase casitas B-lineage lymphoma-b (Cbl-b) modulates peripheral regulatory T cell tolerance in patients with systemic lupus erythematosus.

An increased CD25-positive intestinal regulatory T lymphocyte population is dependent upon Cox-2 activity in the Apc<sup>min/+</sup> model.

Immunoproteasome in the blood plasma of children with acute appendicitis, and its correlation with proteasome and UCHL1 measured by SPR imaging biosensors.

Issue Information.

Self-dsDNA in the pathogenesis of systemic lupus erythematosus.

Ovarian cancer stem cells promote tumour immune privilege and invasion via CCL5 and regulatory T cells.

Chronic exposure of interleukin-13 suppress the induction of matrix metalloproteinase-1 by tumour necrosis factor α in normal and scleroderma dermal fibroblasts through protein kinase B/Akt.

Selective HDAC6 inhibition decreases early stage of lupus nephritis by down-regulating both innate and adaptive immune responses.

Expression of human cathelicidin peptide LL-37 in inflammatory bowel disease.

DC-SIGN reacts with TLR-4 and regulates inflammatory cytokine expression via NF-κB activation in renal tubular epithelial cells during acute renal injury.

Is Behçet's disease a 'class 1-opathy'? The role of HLA-B*51 in the pathogenesis of Behçet's disease.